The global pharmaceuticals and food anti-counterfeiting market is expected to reach USD 160.32 billion by 2020, according to a new study by Grand View Research, Inc. The rise in the consumption of counterfeit products and the implementation of strict regulations pertaining to anti-counterfeiting by the U.S. FDA are two of the primary growth drivers of this market. Moreover, anti-counterfeiting initiatives undertaken by manufacturers to curb revenue and brand image losses, the introduction of technological advancements such as ultra-high RFID tags and the high scale of counterfeiting in rapidly growing economies such as Brazil, India, China and Russia will serve this market as drivers.
RFID based pharmaceuticals and food anti-counterfeiting technologies are expected to be the most attractive markets and are estimated to grow at a CAGR of approximately 20% from 2013 to 2020. Its ability to reduce costs associated with food and drug recalls, track products along the supply chain and provide real time access to drug and food packaging is one of the factors attributing to its high CAGR. Moreover, unique EPC (electronic product code) inscribed on a RFID chip significantly reduces the chances of counterfeiting.
To request a sample copy or view summary of this report, click the link :